Actively Recruiting
Observational Study to Validate CLAiR AI Software for Detecting Elevated Cardiovascular Risk Using Retinal Images in Adults Aged 40 to 75
Led by Toku Eyes Ltd · Updated on 2025-03-25
942
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multi-site observational study to validate the CLAiR AI softwares ability to identify elevated risk for atherosclerotic cardiovascular disease ASCVD using retinal images. This study compares the CLAiR softwares predictions to the established Pooled Cohort Equations PCE risk score, which estimates ASCVD risk over the next 10 years. The goal is to assess whether CLAiR can accurately classify individuals as having elevated or non-elevated risk based on retinal photos and basic demographic data. Participants will have retinal images taken with two different camera models and these images will be uploaded to the CLAiR software for analysis. There is no direct medical intervention or contact with the software by participants. The study collects retinal photos along with clinical biomarker data to evaluate the AI models performance compared to the PCE score. This observational study runs for approximately six months on average for each participant. During the study, participants will provide informed consent and comply with study procedures, including retinal imaging and data collection. Researchers will measure the accuracy of CLAiR in identifying elevated ASCVD risk by comparing its results to the PCE risk score. Safety monitoring is minimal as this is an observational study without drug or device treatment. The total study duration varies but generally involves data collection and follow-up within six months.
CONDITIONS
Brief Title
CLAiR Pivotal Study
Research Team
Y
Yariv Levinson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here